Future Health ESG Corp.

Future Health ESG Corp., a Delaware corporation (the “ Company ”), has determined that it is unable to finalize its financial results without unreasonable effort or expense. The Company is working diligently to complete its Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2024 (the “ Q2 2024 Form 10-Q ”) as soon as possible; however, the Company requires additional time to compile and verify the data required to be included in the Q2 2024 Form 10-Q, and will be unable to complete and file the Q2 2024 Form 10-Q by the required due date of August 14, 2024. The Company does, however, expect to file the Q2 2024 Form 10-Q within five calendar days thereof. (1) Name and telephone number of person to contact in regard to this notification. Khairul Azmi Bin Ismaon (833) 388-8734 (Name) (Area Code) (Telephone Number) (2) Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s). Yes x No ¨ (3) Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof? Yes ¨ No x If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made. Future Health ESG Corp. (Name of Registrant as Specified in Charter) has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized. Date: August 15, 2024 By: /s/ Khairul Azmi Bin Ismaon Khairul Azmi Bin Ismaon Chief Executive Officer

On May 14, 2024, Future Health ESG Corp. (the “Company”) filed a Notification of Late Filing on Form 12b-25 (the “Original Form 12b-25”) reporting that it required additional time to complete its Quarterly Report on Form 10-Q for the quarter ended March 31, 2024 (the “Form 10-Q”) because the Company was in the process of finalizing the financial statements for the quarter ended March 31, 2024 (the “Financial Statements”). This amendment to the Original Form 12b-25 is being filed to report that the Company will not be filing such Form 10-Q within the five-day extension period provided by the Original Form 12b-25. To date, the Company has been unable, without unreasonable effort or expense, to finalize the Financial Statements for inclusion in the Form 10-Q. The Company is continuing in its efforts to file the Form 10-Q as soon as reasonably practicable. (1) Name and telephone number of person to contact in regard to this notification. Khairul Azmi Bin Ismaon (833) 388-8734 (Name) (Area Code) (Telephone Number) (2) Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s). Yes x No ¨ (3) Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof? Yes ¨ No x If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made. Future Health ESG Corp. (Name of Registrant as Specified in Charter) has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized

Future Health ESG Corp., a Delaware corporation (the “ Company ”), has determined that it is unable to finalize its financial results without unreasonable effort or expense. The Company is working diligently to complete its Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2024 (the “ Q1 2024 Form 10-Q ”) as soon as possible; however, the Company requires additional time to compile and verify the data required to be included in the Q1 2024 Form 10-Q, and will be unable to complete and file the Q1 2024 Form 10-Q by the required due date of May 15, 2024. The Company does, however, expect to file the Q1 2024 Form 10-Q within five calendar days thereof. (1) Name and telephone number of person to contact in regard to this notification. Jesvin Kaur (833) 388-8734 (Name) (Area Code) (Telephone Number) (2) Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s). Yes x No ¨ (3) Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof? Yes ¨ No x If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made. Future Health ESG Corp. (Name of Registrant as Specified in Charter) has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized. Date: May 14, 2024 By: /s/ Jesvin Kaur Jesvin Kaur Chief Executive Officer

Future Health ESG Corp., a Delaware corporation (the “ Company ”), has determined that it is unable to finalize its financial results without unreasonable effort or expense. The Company is working diligently to complete its Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2022 (the “ Q2 2022 Form 10-Q ”) as soon as possible; however, the Company requires additional time to compile and verify the data required to be included in the Q2 2022 Form 10-Q, and will be unable to complete and file the Q2 2022 Form 10-Q by the required due date of August 15, 2022. The Company does, however, expect to file the Q2 2022 Form 10-Q within five calendar days thereof. (1) Name and telephone number of person to contact in regard to this notification. Bradley A. Bostic (833) 388-8734 (Name) (Area Code) (Telephone Number) (2) Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s). Yes x No ¨ (3) Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof? Yes ¨ No x If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made. Future Health ESG Corp. (Name of Registrant as Specified in Charter) has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized. Date: August 15, 2022 By: /s/ Bradley A. Bostic Bradley A. Bostic Chief Executive Officer

Future Health ESG Corp. (the “Registrant”) has elected not to file its quarterly report on Form 10-Q for the fiscal quarter ended September 30, 2021 (the “Form 10-Q”) and is filing a Form 12b-25 for a five day extension deemed necessary for the following reason: The Registrant is working diligently to complete the review of the financial statements for the three months ended September 30, 2021 as soon as possible; however, the Registrant is unable to complete and file the Q3 2021 Form 10-Q by the required due date of November 15, 2021 without unreasonable effort and expense. The Registrant expects to file such report by November 22, 2021. PART IV -- OTHER INFORMATION (1) Name and telephone number of person to contact in regard to this notification Travis Morgan 833-388-8734 (Name) (Area Code) (Telephone Number) (2) Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s). x Yes ¨ No (3) Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof? x Yes ¨ No If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made. See attachment. Future Health ESG Corp. (Name of Registrant as Specified in Charter) has caused this notification to be signed on its behalf by the undersigned thereunto duly authorized